Aspira Pathlab Board Meeting for Q2 FY27 Results

Meeting Date: Friday, November 06, 2026
Primary Agenda: To consider and approve the Un-Audited Standalone Financial Results of the Company along with Limited Review Report for the second quarter/half year ended September 30, 2026
Additional Agenda: To consider other businesses (unspecified)

Trading Window Closure: The Trading Window for dealing in the Securities of the Company shall remain closed till 48 hours after the declaration of the Financial Results
Regulatory Basis: SEBI (Prohibition of Insider Trading) Regulations, 2015 and the Company's Code of Conduct for Regulating, Monitoring and Reporting of Trading in securities by Designated Persons and Immediate Relative Person
Website Disclosure: The notice of the Board Meeting will be uploaded on the Company's website (www.aspiradiagnostics.com) as per regulation 46(2)(l)(i) of the Listing Regulations

Financial impact not quantified in the disclosure. The meeting is for consideration and approval of financial results.